SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Visualisation of lenticulostriate arteries using contrast-enhanced time-of-flight magnetic resonance angiography at 7 Tesla.

Osuafor, CN; Rua, C; Mackinnon, AD; Egle, M; Benjamin, P; Tozer, DJ; Rodgers, CT; Markus, HS (2022) Visualisation of lenticulostriate arteries using contrast-enhanced time-of-flight magnetic resonance angiography at 7 Tesla. Sci Rep, 12 (1). p. 20306. ISSN 2045-2322 https://doi.org/10.1038/s41598-022-24832-z
SGUL Authors: MacKinnon, Andrew David

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Supplementary Information) Published Version
Available under License Creative Commons Attribution.

Download (567kB)

Abstract

7 Tesla-field-strength (7 T) Magnetic Resonance Imaging allows the small perforating arteries in the brain to be visualised, and this modality may allow visualisation of the arterial pathology in cerebral small vessel disease. Most studies have used standard Time-of-Flight (ToF) Magnetic Resonance Angiography (MRA). Whether the use of contrast enhancement improves perforating artery visualisation at 7 T remains unclear. In a prospective study, we compared standard ToF MRA with contrast-enhanced (CE) ToF MRA at 7 T for the visualisation of the lenticulostriate arteries (LSAs). Ten patients with symptomatic lacunar stroke were recruited (mean age, SD, 64 ± 9.9 years). Visualisation was assessed using a visual rating scale administered by two independent expert readers and length of the LSAs visible. Visualisation of the LSAs was improved with CE ToF MRA. The mean Visibility and Sharpness Score was higher for CE ToF MRA over standard ToF MRA (2.55 ± 0.64 vs. 1.75 ± 0.68; P = 0.0008). The mean length of LSA visualised was significantly longer with CE ToF MRA compared to standard ToF MRA (24.4 ± 4.5 vs. 21.9 ± 4.0 mm; P = 0.01). CE ToF MRA offers improved visualisation of the LSAs over standard ToF MRA. The addition of contrast may improve the ability to visualise cerebral small vessel disease arterial pathology.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2022
Keywords: Humans, Middle Aged, Aged, Magnetic Resonance Angiography, Prospective Studies, Middle Cerebral Artery, Magnetic Resonance Imaging, Cerebral Small Vessel Diseases, Middle Cerebral Artery, Humans, Magnetic Resonance Imaging, Magnetic Resonance Angiography, Prospective Studies, Aged, Middle Aged, Cerebral Small Vessel Diseases
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Sci Rep
ISSN: 2045-2322
Language: eng
Dates:
DateEvent
24 November 2022Published
21 November 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
PG/19/74/34670British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
BRC-1215-20014National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
RE/18/1/34212British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 36434036
Web of Science ID: WOS:001002473700029
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115536
Publisher's version: https://doi.org/10.1038/s41598-022-24832-z

Actions (login required)

Edit Item Edit Item